WT1 as a Universal Marker for Minimal Residual Disease Detection and Quantification in Myeloid Leukemias and in Myelodysplastic Syndrome

Publisher： Karger

E-ISSN： 1421-9662|112|1-2|79-84

ISSN： 0001-5792

Source： Acta Haematologica, Vol.112, Iss.1-2, 2004-06, pp. : 79-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

wt1 Gene Expression in Childhood Leukemias

By  

Acta Haematologica, Vol. 102, Iss. 2, 1999-10 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

wt1 Gene Expression in Childhood Acute Leukemias

By  

Acta Haematologica, Vol. 103, Iss. 4, 2000-09 ,pp. : 229-230

Karger

Access to resources Recommend Favorite

Immunological Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 442-448

Karger

Access to resources Recommend Favorite